Renal Management in the Critically Ill Patient

Surgical Clinics of North America

Volumn 92, Issue 6, 2012, Pages 1503-1518

  Waxman, Kenneth S ^a   Holmes, Galen ^a  

^a Ventura County Health Care Agency   (United States)

Author keywords

Acute kidney injury; Peritoneal dialysis; Prerenal azotemia; Renal function

Indexed keywords

ADEFOVIR; ALLOPURINOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; BETA LACTAM ANTIBIOTIC; BIOLOGICAL MARKER; CIDOFOVIR; CIMETIDINE; CISPLATIN; CYSTATIN C; FOSCARNET; HETASTARCH; IMMUNOGLOBULIN; INDINAVIR; IODINATED CONTRAST MEDIUM; LOOP DIURETIC AGENT; MANNITOL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENTAMIDINE; PHENYTOIN; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SARCOLYSIN; TENOFOVIR; TENOFOVIR DISOPROXIL; THIAZIDE DIURETIC AGENT; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HEPATORENAL SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJURY SEVERITY; INTENSIVE CARE UNIT; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY FUNCTION; MICROSCOPY; MORTALITY; NEPHROTOXICITY; PERITONEAL DIALYSIS; PRERENAL AZOTEMIA; PRIORITY JOURNAL; REVIEW; UREMIA; URINALYSIS; URINE VOLUME;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 84869115825     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.08.012     Document Type: Review

References (85)

1. Hoste E., Schurgers M. Epidemiology of acute kidney injury: how big is the problem?. Crit Care Med 2008, 36(4):S146-S151.
2. Chertow G.M., Burdick E., Honour M., et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16:3365-3370.
3. Vieira J.M., Castro I., Curvello-Neto A., et al. Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients. Crit Care Med 2007, 35(1):184-191.
4. Kheterpal S. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology 2007, 17(6):892-902.
5. Waikar S., Curhan G., Wald R., et al. Declining mortality in patients with acute renal failure, 1988-2002. J Am Soc Nephrol 2006, 17:1143-1150.
6. Xue J., Daniels F., Star R., et al. Incidence and mortality in patients with acute renal failure in Medicare beneficiaries, 1992-2001. J Am Soc Nephrol 2006, 17:1135-1142.
7. Bellomo R., Ronco C., Kellum J., et al. Acute renal failure: definitions, outcome measures, animal models, fluid therapy and information technology needs. The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADOQI) Group. Crit Care 2004, 8:R204-R212.
8. Hoste E.A., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10:R73.
9. Osterman M., Chang R. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007, 35:1837-1843.
10. Mehta R., Kellum J., Shah S., et al. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
11. Barrantes F., Tian J., Vazquez R., et al. Acute kidney injury criteria predict outcomes of critically ill patients. Crit Care Med 2008, 36(5):1397-1403.
12. Coca S.G., Peixoto A.J., Garg A.X., et al. The prognostic importance of a small decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis 2007, 50(5):712-720.
13. Peixoto A.J. Birth, death, and resurrection of the physical exam: clinical and academic perspectives on bedside diagnosis. Yale J Biol Med 2001, 74(4):221-228.
14. Crowley S.T., Peixoto A.J. Acute kidney injury in the intensive care unit. Clin Chest Med 2009, 30(1):29-43.
15. Steiner R.W. Interpreting the fractional excretion of sodium. Am J Med 1984, 77:699.
16. Cavounis C.P., Nisar S., Guro-Razuman S. Significance of fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002, 62(6):2223-2229.
17. Miller T.R., Anderson R.J., Linas S.L., et al. Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med 1978, 89(1):47.
18. Espinel C.H., Gregory A.W. Differential diagnosis of acute renal failure. Clin Nephrol 1980, 13:73.
19. Esson M.L., Shrier R.W. Diagnosis and treatment of acute tubular necrosis. Ann Intern Med 2002, 137:744.
20. Perazella M.A., Coca S.G., Kanbay M., et al. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2008, 3:1615.
21. Beier K., Eppanapally S., Bazick H.S., et al. Elevation of blood urea nitrogen is predictive of long-term mortality in critically ill patients independent of " normal" creatinine. Crit Care Med 2011, 39(2):305-313.
22. Belcher J.M., Edelstein C.L., Parikh C.R. Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis 2011, 57(6):930-940.
23. Parikh C.R., Jani A., Melnikov V.Y., et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004, 43(3):404-415.
24. Nickolas T.L., O'Rouke M.J., Yang J., et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008, 148(11):810-819.
25. Haase M., Bellomo R., Devarajan P., et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 56(6):1012-1024.
26. Herget-Rosenthal S., Marggraf G., Husing J., et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004, 66:1115-1122.
27. Le Bricon T., Leblanc I., Benlakehal M., et al. Evaluation of renal function in intensive care: plasma cystatin C vs. creatinine and derived glomerular filtration rate estimates. Clin Chem Lab Med 2005, 43:953-957.
28. Delanaye P., Lambermont B., Chapelle J.P., et al. Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Med 2004, 30:980-983.
29. Villa P., Jimenez M., Soriano M.C., et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care 2005, 9:R139-R143.
30. Koyner J.L., Bennett M.R., Worcester E.M., et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008, 74:1059-1069.
31. Portilla D., Dent C., Sugaya T., et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008, 73(4):465-472.
32. Ritchie W.W., Vick C.W., Glocheski S.K., et al. Evaluation of azotemic patients: diagnostic yield of initial US examination. Radiology 1988, 167:245-247.
33. Yassa N.A., Peng M., Ralls P.W. Perirenal lucency (" kidney sweat"): a new sign of renal failure. AJR Am J Roentgenol 1999, 173:1075-1077.
34. Capotondo L. The role of color Doppler in acute kidney injury. Arch Ital Urol Androl 2010, 82(4):275-279.
35. Schneider A. Bench-to-bedside review: contrast enhanced ultrasonography. A promising technique to assess renal perfusion in the ICU. Crit Care 2011, 15(3):157.
36. Lee J.K., Baron R.L., Melson G.L., et al. Can real-time ultrasonography replace static B-scanning in the diagnosis of renal obstruction?. Radiology 1981, 139:161-165.
37. Ellenbogen P.H., Schieble F.W., Talner L.B., et al. Sensitivity of gray scale US in detecting urinary tract obstruction. Am J Roentgenol 1978, 130:731-733.
38. Stuck K.J., White G.M., Granke D.S., et al. Urinary obstruction in azotemic patients: detection by sonography. Am J Roentgenol 1987, 149:1191-1193.
39. Taal. Brenner and Rector's the kidney, 9th ed.
40. Rocci M.L., Vlasses P.H., Ferguson R.K. Creatinine serum concentrations and H2-receptor antagonists. Clin Nephrol 1984, 22(4):214.
41. Berg K.J., Gjellestad A., Nordby G., et al. Renal effects of trimethoprim in ciclosporin- and azathioprine-treated kidney-allografted patients. Nephron 1989, 53(3):218.
42. Vrouenraets S.M., Fux C.A., Wit F.W., et al. Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity. AIDS 2011, 25(17):2149-2155.
43. Cheatham M.L. Nonoperative management of intraabdominal hypertension and abdominal compartment syndrome. World J Surg 2009, 33:1116-1122.
44. Perazella M.A., Markowitz G.S. Drug-induced acute interstitial nephritis. Nat Rev Nephrol 2010, 6(8):461-470.
45. Gonzalez E., Gutierrez E., Galeano C., et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 2008, 73(8):940-946.
46. Ehrenpreis E.D., Parakkal D., Semer R., et al. Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US FOOD and Drug Administration. Colorectal Dis 2011, 13(9):e270-e275.
47. Malaguarnera G., Giordana M., Malaguarnera M. Rasburicase for the treatment of tumor lysis in hematological malignancies. Expert Rev Hematol 2012, 5(1):27-38.
48. Lameire N.H. The pathophysiology of acute renal failure. Crit Care Med 2005, 21:197-210.
49. Kellum J.A. Acute kidney injury. Crit Care Med 2008, 36(4):S141-S145.
50. Persson P.B., Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Kidney Int Suppl 2006, 100:S8-S10.
51. Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002, 39:930-936.
52. Nainani N., Panesar M. Nephrogenic systemic fibrosis. Am J Nephrol 2009, 29:1-9.
53. Barret B.J., Carlisle E.J. Meta-analysis of the relative nephrotoxicity of high and low-osmolality iodinated contrast media. Radiology 1993, 188:171-178.
54. Brar S.S., Shen A.Y., Jorgensen M.B., et al. Sodium bicarbonate vs. sodium chloride for the prevention of contrast medium-induced nephropathy in patients in patients undergoing coronary angiography: a randomized trial. JAMA 2008, 300:1038-1046.
55. Tepel M., van der Giet M., Schwarzfeld C., et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000, 343:180-184.
56. Kelly A.M., Dwamena B., Cronin P., et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008, 148:284-294.
57. Dennen P., Douglas I.S., Anderson R. Acute kidney injury in the intensive care unit: an update and primer for the intensivist. Crit Care Med 2010, 38(1):261-275.
58. Finfer S., Bellomo R., Boyce N., et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004, 350:2247-2256.
59. Wiedermann C.J. Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 2008, 8:1.
60. Payen D., de Pont A.C., Sakr Y., et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care 2008, 12:R74.
61. Wiedemann H.P., Wheeler A.P., Bernard G.R., et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575.
62. Endre Z.H., Walker R.J., Pickering J.W., et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010, 77:1020-1030.
63. Patel N., Collino M., Yaqoob M., et al. Erythropoietin in the intensive care unit: beyond treatment of anemia. Ann Intensive Care 2011, 1:40.
64. Venkataram R., Kellum J.A. The role of diuretic agents in the management of acute renal failure. Contrib Nephrol 2001, 158-170.
65. van Valenberg P.L., Hoitsma A.J., Tiggeler R.G., et al. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation. Transplantation 1987, 44:784-788.
66. Better O.S., Rubinstein I. Management of shock and acute renal failure in casualties suffering from the crush syndrome. Ren Fail 1997, 19:647-653.
67. Grams M.E., Estrella M.M., Coresh J., et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011, 6(5):966-973.
68. Sward K., Valsson F., Odencrants P., et al. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004, 32:1310-1315.
69. Lewis J., Salem M.M., Chertow G.M., et al. Atrial natriuretic factor in oliguric acute renal failure. Anaritide acute renal failure study group. Am J Kidney Dis 2000, 36:767-774.
70. Meyer M., Pfarr E., Schirmer G., et al. Therapeutic use of the natriuretic peptide ularitide in acute renal failure. Ren Fail 1999, 21:85-100.
71. Lauschke A., Teichgraber U.K., Frei U., et al. 'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 2006, 69:1669-1674.
72. Landoni G., Biondi-Zoccai G.G., Tumlin J.A., et al. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis 2007, 49(1):56-68.
73. Heemskerk S., Masereeuw R., Moesker O., et al. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients. Crit Care Med 2009, 37(2):417-423.
74. Chi A., Lissauer M.E., Kirchoffner J., et al. Effect of glycemic state on hospital mortality in critically ill surgical patients. Am Surg 2011, 77(11):1483-1489.
75. Schetz M., Vanhorebeek I., Wouters P.J., et al. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 2008, 19:571-578.
76. Finfer S., Chittock D.R., Su S.Y., et al. Intensive vs. conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
77. Pierson D.J. Respiratory considerations in the patient with renal failure. Respir Care 2006, 51(4):413-422.
78. Uchino S., Kellum J.A., Bellomo R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294:813-818.
79. Bagshaw S.M., Uchino S., Bellomo R., et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care 2009, 24:129-140.
80. Palevsky P.M., Zhang J.H., O'Connor T.Z., et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359:7-20.
81. Bagshaw S.M., Berthiaume L.R., Delaney A., et al. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med 2008, 36(2):610-617.
82. Molitch M.E., Rodman E., Hirsch C.A., et al. Spurious serum creatinine elevations in ketoacidosis. Ann Intern Med 1980, 93(2):280.
83. Saah A.J., Koch T.R., Drusano G.L. Cefoxitin falsely elevates creatinine levels. JAMA 1982, 247(2):205.
84. Mitchell E.K. Flucytosine and false elevation of serum creatinine level. Ann Intern Med 1984, 101(2):278.
85. Herrington D., Drusano G.L., Smalls U., et al. False elevation in serum creatinine levels. JAMA 1984, 252(21):2962.